These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3204165)

  • 1. Fatal susceptibility to cycloheximide of mice bearing Ehrlich ascites tumours and of animals pretreated with cell-free Ehrlich ascites tumour fluid.
    Parry EW
    J Comp Pathol; 1988 Oct; 99(3):309-15. PubMed ID: 3204165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of cycloheximide, heparin and ancrod on mice given Ehrlich ascites tumour cells intravenously.
    Parry EW
    J Comp Pathol; 1985 Apr; 95(2):203-7. PubMed ID: 3837790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lethal syndrome following intravenous injection of Ehrlich ascites tumour cells in cycloheximide-treated mice and its prevention by heparin.
    Parry EW
    J Comp Pathol; 1984 Jan; 94(1):93-9. PubMed ID: 6699233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrocortisone protects cycloheximide-challenged mice pretreated with Ehrlich ascites tumour cells or with cell-free Ehrlich ascites tumour fluid.
    Parry EW
    J Comp Pathol; 1990 Oct; 103(3):315-9. PubMed ID: 2258469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of intravenously injected Ehrlich ascites tumour cells in cycloheximide-treated mice.
    Parry EW
    Gan; 1980 Dec; 71(6):907-9. PubMed ID: 7306373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cycloheximide challenge of mice bearing subcutaneous tumours, with observations on heparin treatment.
    Parry EW
    J Comp Pathol; 1984 Jan; 94(1):101-6. PubMed ID: 6699220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cycloheximide treatment modifies the pattern of "metastasis" following intravenous injection of Ehrlich ascites tumour cells.
    Parry EW
    Gan; 1981 Jun; 72(3):464-7. PubMed ID: 7319203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors involved in the fatal susceptibility to submicrogram doses of endotoxin in cycloheximide-treated mice.
    Parry EW
    J Comp Pathol; 1989 Jan; 100(1):13-8. PubMed ID: 2645318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some inhibitory effects of (--)-emetine on growth of Ehrlich ascites carcinoma.
    Johnson RK; Jondorf WR
    Biochem J; 1974 Apr; 140(1):87-94. PubMed ID: 4451553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of endotoxin pretreatment on subsequent challenge of mice with cycloheximide and a small dose of endotoxin.
    Parry EW
    J Comp Pathol; 1989 Nov; 101(4):381-8. PubMed ID: 2607012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further analysis of lethal factors in cycloheximide-treated mice given low doses of bacterial lipopolysaccharide.
    Parry EW
    J Comp Pathol; 1989 Feb; 100(2):155-60. PubMed ID: 2715398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of hepatocellular mitosis with carbon tetrachloride in late-phase Ehrlich ascites tumour-bearing mice.
    Parry EW
    Gan; 1975 Feb; 66(1):99-101. PubMed ID: 1150004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour-associated hepatocellular mitosis in Ehrlich ascites tumour-bearing mice.
    Parry EW
    Gan; 1976 Aug; 67(4):585-93. PubMed ID: 1030680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by cell-free Ehrlich ascites tumour fluid of the resolution of carbon tetrachloride-induced hepatorenal necrosis in mice.
    Parry EW
    Gan; 1979 Jun; 70(3):267-72. PubMed ID: 556351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in the amount of nuclear RNA in liver of ascites tumour-bearing mice.
    Andersson G; Christensson E; Heby O
    Acta Pathol Microbiol Scand A; 1976 May; 84(3):225-34. PubMed ID: 1274587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Ehrlich ascites tumour on the clinical course and pathology of mice having carbon tetrachloride-induced hepato-renal necrosis.
    Parry EW
    Gan; 1978 Apr; 69(2):159-66. PubMed ID: 680460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host zinc metabolism and the Ehrlich ascites tumour. Zinc redistribution during tumour-related stress.
    Ujjani B; Krakower G; Bachowski G; Krezoski S; Shaw CF; Petering DH
    Biochem J; 1986 Jan; 233(1):99-105. PubMed ID: 3954737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of bearing tumours on the ability of mice to reject bone marrow transplants.
    Miller SC; Nguyen D; Bird IA
    Scand J Immunol; 1988 Apr; 27(4):427-32. PubMed ID: 3283920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method for an increase of the number of anaphases in Ehrlich ascites tumour cells in mouse.
    Bogajewski J
    Acta Anthropogenet; 1983; 7(4):331-49. PubMed ID: 6680313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H-thymidine incorporation into the DNA of the nucleic factor in the ascitic fluid of Ehrlich cancer].
    Belokhvostov AS
    Eksp Onkol; 1985; 7(6):50-3. PubMed ID: 4085399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.